## Note
nid: 1518029558418
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Pathoma_Chapter_3_(Neoplasia), #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::17_Paraneoplastic_Syndromes, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::17_Paraneoplastic_Syndromes::Hypercalcemia, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pathoma::03_Neoplasia::Extra::Paraneoplastic_Syndromes, #AK_Step1_v11::#Pathoma::03_Neoplasia_Alt_Tagging::BlueGalaxies::Paraneoplastic_Syndromes, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^FA_Updates::FA2018
markdown: false

### Text
The hypercalcemia seen in patients with <u>Humoral Hypercalcemia of
Malignancy</u> is mediated by {{c1::PTHrP}}

### Extra
- PTHrP can act on the <b>PTH receptor</b>, resulting in
hypercalcemia
<div>
  - endogenously, PTHrP has other functions in the body including
  <u>regulation of the endochondral growth plate</u> and
  <u>formation of the mammary glands</u>
</div>
<div>
  <u><img src="paste-12481174962177%20(1).jpg"></u>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

